Israeli Doctors Unveil New Research Into Cancer Testing, Alzheimer’s, IVF

December 11, 2017 | Israel’s Sheba Medical Center at Tel Hashomer hospital, the largest medical facility in the country, announced that three of its research doctors have unveiled new breakthroughs in cancer testing, Alzheimer’s disease indicators, and IVF treatment. The hospital said Dr. Damien Urban, head of the Oncology Department at the Cancer Center at Sheba Medical Center, has created the first Rapid Cancer Diagnostic Testing Center in Israel, which allows people to cut the long process of medical testing and bureaucracy to just two weeks. In the past, learning the nature of a cancerous growth could take as long as three months. As part of Sheba’s Neuroscience Division, Dr. Michal Schnaider Beeri is employing advanced tech to detect indications of early-stage Alzheimer’s disease. Research and testing are currently being done with 1,5000 high-risk patients using “retinal amyloid technology.” And Dr. Ronit Machtinger, a senior physician in the IVF Unit of the Department of Obstetrics and Gynecology, in the midst of intense research with counterparts at Harvard Medical School and Columbia University, has discovered that women undergoing IVF treatments can increase their chances of conceiving by significantly reducing their consumption of soft drinks. Located in Ramat Gan, just east of Tel Aviv, Sheba Medical Center is home to the largest percentage of clinical research in Israel being done in a single hospital.